Precision Biosensor is holding poster presentation at the symposium of The Korean Society for Biomaterials held on 18th till 19th of October.
The title of Precision Biosensor's poster is “Development of Acute Myocardial Infarction Diagnostic technology with Time-Resolved Fluorescence Detection”.
It will be announced on session titled "Performance Report of Korea Evaluation Institute of Industrial Technology (KEIT)".
The announcement of Precision Biosensor is about the development of technology that solves the problem of diagnostic sensitivity and precision limit of membrane-based immunoassay by directly controlling the liquid without using membrane.
The Korean Society for Biomaterials is where many professors and researchers in biomaterial field participate. In this conference, there will be Young Scientist Exchange Program of Korea, China, and Japan and WISET-KSBM of young researchers at the same time. Through such activities, the 12th World Biomaterials Congress (WBC) 2024, which is held every four years, has been successfully invited to Daegu, South Korea.
Precision Biosensor is a company that possess the solution from development and manufacture to distribution of immunodiagnostic products. Precision Biosensor invests large portion in R&D to develop technology in a better way. This announcement of Precision Biosensor is of a technology that will give more diagnostic confidence to people in POCT environment.